Malden, MA, United States of America

Xun Zhang

This inventor holds 4 USPTO granted patents. Top assignee: Cedars-Sinai Medical Center. Active years: 2004-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xun Zhang. Retrieved from https://idiyas.com/inventor/xun-zhang-3eud0rel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 25.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2004-2005

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Xun Zhang in Cancer Research

Introduction

Xun Zhang is a notable inventor based in Malden, MA, who has made significant contributions to the field of cancer research. He holds four patents that focus on innovative methods and compositions aimed at inhibiting neoplastic cellular proliferation and transformation.

Latest Patents

One of his latest patents involves antibodies against mouse pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptides. These isolated antibodies specifically bind to murine PTTG-C peptides and are useful in assays to determine levels of PTTG proteins or PTTG-C peptides in various samples. The antibodies can also purify PTTG proteins from crude cell extracts and are considered therapeutically beneficial in counteracting the biological effects of PTTG proteins in vivo.

Another significant patent discloses a method for inhibiting neoplastic cellular proliferation and transformation of mammalian cells. This method utilizes PTTG-C peptides to regulate PTTG expression and function in a dominant negative manner. The invention includes gene-based treatments that deliver PTTG-C-related polynucleotides to inhibit endogenous PTTG expression. Additionally, it covers peptide-based treatments that deliver PTTG-C peptide molecules to inhibit PTTG function. The patent also discusses methods for inhibiting tumor angiogenesis and compositions that include PTTG carboxy-terminal peptides or related polynucleotides.

Career Highlights

Xun Zhang is currently affiliated with Cedars-Sinai Medical Center, where he continues to advance his research in cancer therapeutics. His work has the potential to significantly impact the treatment of tumors and related conditions.

Collaborations

Xun Zhang has collaborated with notable colleagues such as Gregory A. Horwitz and Shlomo Melmed, contributing to the advancement of research in his field.

Conclusion

Xun Zhang's innovative patents and research efforts are paving the way for new therapeutic approaches in cancer treatment. His work exemplifies the critical role of inventors in advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…